Reviva Pharmaceuticals Ownership | Who Owns Reviva Pharmaceuticals?


OverviewForecastFinancialsChart

Reviva Pharmaceuticals Ownership Summary


Reviva Pharmaceuticals is owned by 22.17% institutional investors, 10.58% insiders, and 67.25% retail investors. Millennium management is the largest institutional shareholder, holding 5.34% of RVPH shares. Vanguard Total Stock Mkt Idx Inv is the top mutual fund, with 2.61% of its assets in Reviva Pharmaceuticals shares.

RVPH Ownership Benchmark


TypeName% Inst% Insiders% Retail
StockReviva Pharmaceuticals22.17%10.58%67.25%
SectorHealthcare Stocks 279.18%10.62%-189.80%
IndustryBiotech Stocks 63.96%10.74%25.30%

Institutional Shareholders


Top Institutional Shareholders by Total Shares

HolderShares% HoldingValue
Millennium management1.80M5.34%$3.27M
Vanguard group1.38M4.10%$2.51M
Schonfeld strategic advisors1.06M3.13%$1.92M
Geode capital management311.70K0.92%$564.28K
Susquehanna group, llp202.01K0.60%$365.64K
Tang capital management170.00K0.50%$307.70K
Blackrock102.93K0.43%$131.75K
Blackrock funding, inc. /de115.10K0.34%$208.33K
State street99.40K0.29%$179.91K
Northern trust57.75K0.24%$73.92K

Top Institutional Shareholders by % of Total Assets

HolderShares% AssetsValue
Emc capital management44.53K0.05%$81.00K
Tang capital management170.00K0.02%$307.70K
Nri wealth management lc12.38K0.02%$22.41M
Schonfeld strategic advisors1.06M0.01%$1.92M
Drive wealth management20.00K0.01%$36.20K
Pale fire capital se25.00K0.00%$32.00K
Sound income strategies30.00K0.00%$54.30K
Millennium management1.80M0.00%$3.27M
Tower research capital llc (trc)26.77K0.00%$48.46K
Avantax advisory services60.00K0.00%$108.60K

Top Buyers

HolderShares% AssetsChange
Vanguard group1.38M-359.34K
Tang capital management170.00K0.02%170.00K
Susquehanna group, llp202.01K0.00%138.84K
Geode capital management311.70K-33.20K
State street99.40K-28.00K

Top Sellers

HolderShares% AssetsChange
Armistice capital---1.36M
Woodline partners lp---684.80K
Parkman healthcare partners---514.27K
Schonfeld strategic advisors1.06M0.01%-457.80K
Sabby management---237.00K

New Positions

HolderShares% AssetsChangeValue
Tang capital management170.00K0.02%170.00K$307.70K
Drive wealth management20.00K0.01%20.00K$36.20K
Wolverine trading14.26K-14.26K$25.81K
Raymond james financial14.00K-14.00K$25.34K
Nri wealth management lc12.38K0.02%12.38K$22.41M

Sold Out

HolderChange
Qube research-50.00
Wolverine asset management-122.00
Wells fargo & company/mn-175.00
Jpmorgan chase-235.00
Advisor group-250.00

Institutional Ownership Trends


DateHoldingsChange %SharesChange %OwnershipChange %Increased PositionChange %Decreased PositionChange %
Mar 31, 2025538.16%7,348,669-4.96%224.24%29-3.33%912.50%
Dec 31, 20244932.43%7,732,309-22.27%222.64%30100.00%8-11.11%
Sep 30, 2024375.71%9,947,22745.22%415.10%15-25.00%980.00%
Jun 30, 2024356.06%6,849,68722.89%285.30%2025.00%5-16.67%
Mar 31, 202433-28.26%5,573,8375.84%234.83%16-42.86%6-14.29%

Top Mutual Funds Shareholders


HolderShares% HoldingChange
Vanguard Total Stock Mkt Idx Inv1.22M2.61%-
Vanguard US Total Market Shares ETF700.44K1.50%-
Vanguard Institutional Extnd Mkt Idx Tr573.38K1.23%-
Fidelity Extended Market Index229.66K0.49%67.36K
BlackRock Extended Equity Market K48.10K0.15%-20.00
Northern Trust Extended Eq Market Idx48.87K0.10%14.74K
NT Ext Equity Mkt Idx Fd - L48.87K0.10%14.74K
Extended Equity Market Fund K47.59K0.10%146.00
iShares Micro-Cap ETF47.06K0.10%-
Fidelity Total Market Index46.94K0.10%-

Recent Insider Transactions


DateNameRoleActivityValue
Nov 18, 2022Patel Purav-Buy$14.07K
Sep 30, 2022Narayan Prabhu Chief Financial OfficerBuy$83.00K
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$86.96
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$51.38
Sep 08, 2022VEDANTA PARTNERS, LLC-Buy$2.09M

Insider Transactions Trends


DateBuySell
2024 Q4--
2024 Q3--
2023 Q4--
2023 Q2--
2022 Q41-

RVPH Ownership FAQ


Who Owns Reviva Pharmaceuticals?

Reviva Pharmaceuticals shareholders are primarily institutional investors at 22.17%, followed by 10.58% insiders and 67.25% retail investors. The average institutional ownership in Reviva Pharmaceuticals's industry, Biotech Stocks , is 63.96%, which Reviva Pharmaceuticals falls below.

Who owns the most shares of Reviva Pharmaceuticals?

Reviva Pharmaceuticals’s largest shareholders are Millennium management (1.8M shares, 5.34%), Vanguard group (1.38M shares, 4.10%), and Schonfeld strategic advisors (1.06M shares, 3.13%). Together, they hold 12.56% of Reviva Pharmaceuticals’s total shares outstanding.

Does Blackrock own Reviva Pharmaceuticals?

Yes, BlackRock owns 0.43% of Reviva Pharmaceuticals, totaling 102.93K shares as of Jun 2024. This represents 0% of BlackRock's total assets, with a market value of 131.75K$. In the last quarter, BlackRock increased its holdings by 11.07K shares, a 12.05% change.

Who is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested?

Emc capital management is Reviva Pharmaceuticals’s biggest shareholder by percentage of total assets invested, with 0.05% of its assets in 44.54K Reviva Pharmaceuticals shares, valued at 81K$.

Who is the top mutual fund holder of Reviva Pharmaceuticals shares?

Vanguard Total Stock Mkt Idx Inv is the top mutual fund holder of Reviva Pharmaceuticals shares, with 2.61% of its total shares outstanding invested in 1.22M Reviva Pharmaceuticals shares.

Try Tickergate Pro Free

Customize Everything. 100% Flexibility. Fast and Easy to Use (No code or Excel Needed)

  • Customize your own personal stocks lists, views and charts

  • Choose from hundreds of fields, up to 15 years of history

  • Conduct deep comparison analysis

  • Discover trending investment themes

  • Find your next best investment

  • Research stocks using tools